GNA11 and N-RAS mutations: Alternatives for MAPK pathway activating GNAQ mutations in primary melanocytic tumours of the central nervous system

Neuropathology and Applied Neurobiology

Volumn 39, Issue 4, 2013, Pages 417-425

  Gessi, M ^a   Hammes, J ^a   Lauriola, L ^c   Dorner E ^a   Kirfel, J ^b   Kristiansen, G ^b   zur Muehlen, A ^a   Denkhaus, D ^a   Waha, A ^a   Pietsch, T ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

^c CATHOLIC UNIVERSITY   (Italy)

Author keywords

BRAF; GNA11; GNAQ; N RAS; Primary melanocytic tumours of central nervous system; Pyrosequencing

Indexed keywords

B RAF KINASE; MITOGEN ACTIVATED PROTEIN KINASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CLINICAL ARTICLE; CODON; CYTOPLASM; FEMALE; GENE; GENE MUTATION; GNA11 GENE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MELANOCYTOSIS; ONCOGENE N RAS; PRESCHOOL CHILD; PRIMARY MELANOCYTIC TUMOR; PRIORITY JOURNAL; PYROSEQUENCING; SCHOOL CHILD; SINGLE STRAND CONFORMATION POLYMORPHISM; UVEA MELANOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; CHILD, PRESCHOOL; CODON; DNA, NEOPLASM; EXONS; FEMALE; GENES, RAS; GTP-BINDING PROTEIN ALPHA SUBUNITS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MAP KINASE SIGNALING SYSTEM; MELANOCYTES; MIDDLE AGED; MUTATION; PROTO-ONCOGENE PROTEINS B-RAF; PROTO-ONCOGENE PROTEINS C-KIT; YOUNG ADULT;

EID: 84876842898     PISSN: 03051846     EISSN: 13652990     Source Type: Journal    
DOI: 10.1111/j.1365-2990.2012.01288.x     Document Type: Article

References (25)

1. Brat DJ, Perry A. Melanocytic lesions. In WHO Classification of Tumours of the Central Nervous System 4th edn. Eds DN Louis, H Ohgaki, OD Wiestler, WK Cavenee. Lyon: IARC Press, 2007; 181-3.
2. Brat DJ, Giannini C, Scheithauer BW, Burger PC. Primary melanocytic neoplasms of the central nervous systems. Am J Surg Pathol 1999; 23: 745-54.
3. Burger PC, Scheithauer BW, Vogel FS. Surgical Pathology of the Nervous System and Its Coverings. New York: Churchill Livingstone, 2002.
4. Ghosh P, Chin L. Genetics and genomics of melanoma. Expert Rev Dermatol 2009; 4: 131-43.
5. Poynter JN, Elder JT, Fullen DR, Nair RP, Soengas MS, Johnson TM, Redman B, Thomas NE, Gruber SB. BRAF and NRAS mutations in melanoma and melanocytic nevi. Melanoma Res 2006; 16: 267-73.
6. Küsters-Vandevelde HV, Klaasen A, Küsters B, Groenen PJ, van Engen-van Grunsven IA, van Dijk MR, Reifenberger G, Wesseling P, Blokx WA. Activating mutations of the GNAQ gene: a frequent event in primary melanocytic neoplasms of the central nervous system. Acta Neuropathol 2010; 119: 317-12.
7. Wong CW, Fan YS, Chan TL, Chan AS, Ho LC, Ma TK, Yuen ST, Leung SY, Cancer Genome Project. BRAF and NRAS mutations are uncommon in melanomas arising in diverse internal organs. J Clin Pathol 2005; 58: 640-4.
8. Onken MD, Worley LA, Long MD, Duan S, Council ML, Bowcock AM, Harbour JW. Oncogenic mutations in GNAQ occur early in uveal melanoma. Invest Ophthalmol Vis Sci 2008; 49: 5230-4.
9. Van Raamsdonk CD, Bezrookove V, Green G, Bauer J, Gaugler L, O'Brien JM, Simpson EM, Barsh GS, Bastian BC. Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature 2009; 457: 599-602.
10. Patel M, Smyth E, Chapman PB, Wolchok JD, Schwartz GK, Abramson DH, Carvajal RD. Therapeutic implications of the emerging molecular biology of uveal melanoma. Clin Cancer Res 2011; 17: 2087-100.
11. Lamba S, Felicioni L, Buttitta F, Bleeker FE, Malatesta S, Corbo V, Scarpa A, Rodolfo M, Knowles M, Frattini M, Marchetti A, Bardelli A. Mutational profile of GNAQQ209 in human tumors. Plos ONE 2009; 4: 6833.
12. Van Raamsdonk CD, Griewank KG, Crosby MB, Garrido MC, Vemula S, Wiesner T, Obenauf AC, Wackernagel W, Green G, Bouvier N, Sozen MM, Baimukanova G, Roy R, Heguy A, Dolgalev I, Khanin R, Busam K, Speicher MR, O'Brien J, Bastian BC. Mutations in GNA11 in uveal melanoma. N Engl J Med 2010; 363: 2191-9.
13. Murali R, Wiesner T, Rosenblum MK. Bastian BC GNAQ and GNA11 mutations in melanocytomas of the central nervous system. Acta Neuropathol 2012; 123: 457-459.
14. Strom RG, Shvartsbeyn M, Rosenblum MK, Hameed MR, Nafa K, Mikolaenko I, Babu RP. Melanocytic tumor with GNA11 p.Q209L mutation mimicking a foramen magnum meningioma. Clin Neurol Neurosurg 2012; http://dx.doi.org/10.1016/j.clineuro.2012.02.030.
15. Beadling C, Jacobson-Dunlop E, Hodi FS, Le C, Warrick A, Patterson J, Town A, Harlow A, Cruz F III, Azar S, Rubin BP, Muller S, West R, Heinrich MC, Corless CL. KIT gene mutations and copy number in melanoma subtypes. Clin Cancer Res 2008; 14: 6821-8.
16. Wallander ML, Layfield LJ, Emerson LL, Mamalis N, Davis D, Tripp SR, Holden JA. KIT mutations in ocular melanoma: frequency and anatomic distribution. Mod Pathol 2011; 24: 1031-5.
17. Kraus JA, Bolln C, Wolf HK, Neumann J, Kindermann D, Fimmers R, Forster F, Baumann A, Schlegel U. TP53 alterations and clinical outcome in low grade astrocytomas. Genes Chromosomes Cancer 1994; 10: 143-9.
18. Setty P, Hammes J, Rothämel T, Vladimirova V, Kramm CM, Pietsch T, Waha A. Pyrosequencing-based assay for the rapid detection of IDH1 mutations in clinical samples. J Mol Diagn 2010; 12: 750-6.
19. Haluska FG, Tsao H, Wu H, Haluska FS, Lazar A, Goel V. Genetic alterations in signaling pathways in melanoma. Clin Cancer Res 2006; 12: 2301-7.
20. Platz A, Egyhazi S, Ringborg U, Hansson J. Human cutaneous melanoma; a review of NRAS and BRAF mutation frequencies in relation to histogenetic subclass and body site. Mol Oncol 2008; 1: 395-405.
21. Cruz F III, Rubin BP, Wilson D, Town A, Schroeder A, Haley A, Bainbridge T, Heinrich MC, Corless CL. Absence of BRAF and NRAS mutations in uveal melanoma. Cancer Res 2003; 63: 5761-6.
22. Ji Z, Flaherty KT, Tsao H. Targeting the RAS pathway in melanoma. Trends Mol Med 2012; 18: 27-35.
23. Takata M, Saida T. Genetic alterations in melanocytic tumors. J Dermatol Sci 2006; 43: 1-10.
24. Bastian BC, LeBoit PE, Pinkel D. Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features. Am J Pathol 2000; 157: 967-72.
25. Scolyer RA, Long GV, Thompson JF. Evolving concepts in melanoma classification and their relevance to multidisciplinary melanoma patient care. Mol Oncol 2011; 5: 124-36.